Amended Statement of Beneficial Ownership (3/a)
July 20 2016 - 6:57AM
Edgar (US Regulatory)
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Platinum Partners Value Arbitrage Fund, LP
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/6/2016
|
3. Issuer Name
and
Ticker or Trading Symbol
IMPLANT SCIENCES CORP [IMSC]
|
|
(Last)
(First)
(Middle)
250 WEST 55TH STREET, 14TH FLOOR
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below)
___
X
___ Other (specify below)
/ Not subject to reporting
|
|
(Street)
NEW YORK, NY 10019
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
4/18/2016
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
|
Common Stock par value $0.10
|
2081829
(1)
|
I
|
By MONTSANT PARTNERS, LLC
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
|
March 2009 Note
|
(1)
|
(1)
|
Series J Preferred Stock
|
(1)
|
(1)
|
I
|
By MONTSANT PARTNERS, LLC
|
|
March 2009 Note
|
(1)
|
(1)
|
Common Stock, par value $0.10
|
(1)
|
(1)
|
I
|
By MONTSANT PARTNERS, LLC
|
|
September 2012 Note
|
(1)
|
(1)
|
Series H Preferred Stock
|
(1)
|
(1)
|
I
|
By DMRJ GROUP LLC
|
|
September 2012 Note
|
(1)
|
(1)
|
Common Stock, par value $0.10
|
(1)
|
(1)
|
I
|
By DMRJ GROUP LLC
|
|
February 2013 Note
|
(1)
|
(1)
|
Series I Preferred Stock
|
(1)
|
(1)
|
I
|
By DMRJ GROUP LLC
|
|
February 2013 Note
|
(1)
|
(1)
|
Common Stock, par value $0.10
|
(1)
|
(1)
|
I
|
By DMRJ GROUP LLC
|
|
Explanation of Responses:
|
|
(
1)
|
This amendment is being filed to correct erroneous statements in the Form 3 filed on April 18, 2016 (the "Original Form 3") indicating that the Reporting Persons had certain reportable beneficial ownership of the securities and underlying securities noted above. The Reporting Persons do not and have not beneficially owned 10% or more of any class of equity securities of Implant Sciences Corp registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and, accordingly, are not and have not been Section 16 Reporting Persons with respect to the Issuer. Accordingly, none of the Reporting Persons currently have or have had at any time from (and including) the date of the event reported on the Original Form 3, any obligation to report beneficial ownership on this Form, and the Form has been amended to so reflect.
|
Reporting Owners
|
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Platinum Partners Value Arbitrage Fund, LP
250 WEST 55TH STREET
14TH FLOOR
NEW YORK, NY 10019
|
|
|
|
Not subject to reporting
|
Platinum Management (NY) LLC
250 WEST 55TH STREET
NEW YORK, NY 10019
|
|
|
|
Not subject to reporting
|
DMRJ GROUP LLC
250 WEST 55TH STREET, 14TH FLOOR
NEW YORK, NY 10019
|
|
|
|
Not subject to reporting
|
MONTSANT PARTNERS, LLC
250 WEST 55TH STREET, 14TH FLOOR
NEW YORK, NY 10019
|
|
|
|
Not subject to reporting
|
Nordlicht Mark
250 WEST 55TH STREET
NEW YORK, NY 10019
|
|
|
|
Not subject to reporting
|
Signatures
|
|
/s/ Joseph SanFilippo, Attorney-in-Fact
|
|
7/19/2016
|
|
**
Signature of Reporting Person
|
Date
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|